Near visual acuity and preferred reading distance continue to improve with follow-up to 3 years in patients with presbyopia who received scleral spacing implants (VisAbility Implant System), a researcher said here.
Additional follow-up to the initial 24-month VisAbility multicenter clinical trial demonstrated that 97% of patients receiving bilateral scleral implants achieved binocular distance corrected near visual acuity (DCNVA) at 40 cm of 20/40 (J3) or better at 36 months, an improvement over the 95% of patients who achieved this outcome at 24 months, James Katz, MD, from the Midwest Center for Sight in Des Plaines, Ill., said at the American Academy of Ophthalmology annual meeting.
